The Potential for Immunotherapy In HER2+ Breast Cancer

Video

Debu Tripathy, MD, chair, Breast Medical Oncology, University of Texas MD Anderson Cancer Center, discusses the potential for immunotherapy in the treatment of HER2+ breast cancer.

Newsletter

Stay up to date on practice-changing data in community practice.

Recent Videos
Related Content